While many of these pathways of BCL2L13 co-expressed genes are related to citrate cycle and substance metabolism, these data suggested that BCL2L13 regulated energy and metabolism might be involved in its prognostic role in ccRCC and pRCC patients. The gene discussed is BCL2L13; the disease is nonpapillary renal cell carcinoma.